AACR Annual Meeting 2019: PD-1 Pandemonium
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Category: AACR
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
Persistent infections from pathogens are a major cause of cancer incidence worldwide. An analysis from 2012 indicates that more...
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
Cancer prevention refers to measures that people can take to reduce their risk of developing cancer. These measures can...
The spectacular sight of the AACR Annual Meeting 2019 Opening Ceremony, held Sunday, March 31, at the Georgia World...
Like many Americans, Dr. Jill Biden has been personally affected by cancer. Friends, her parents, and her son Beau...
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...
Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers...
Back for March are the editors’ picks from the portfolio of scientific journals published by the American Association for...